EVOK
Price:
$5.732
Market Cap:
$4.70M
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2013-09-25
Stock Exchange
NASDAQ
Ticker
EVOK
According to Evoke Pharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 518.23K. This represents a change of -98.70% compared to the average of 39.98M of the last 4 quarters.
The mean historical Enterprise Value of Evoke Pharma, Inc. over the last ten years is 333.50M. The current 518.23K Enterprise Value has changed -84.46% with respect to the historical average. Over the past ten years (40 quarters), EVOK's Enterprise Value was at its highest in in the September 2020 quarter at 1.47B. The Enterprise Value was at its lowest in in the June 2024 quarter at 3.54M.
Average
333.50M
Median
324.57M
Minimum
42.38M
Maximum
786.73M
Discovering the peaks and valleys of Evoke Pharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 119.12%
Maximum Annual Enterprise Value = 786.73M
Minimum Annual Increase = -73.51%
Minimum Annual Enterprise Value = 42.38M
Year | Enterprise Value | Change |
---|---|---|
2023 | 42.38M | -56.03% |
2022 | 96.38M | -53.74% |
2021 | 208.37M | -73.51% |
2020 | 786.73M | 83.78% |
2019 | 428.08M | -12.45% |
2018 | 488.96M | 23.32% |
2017 | 396.51M | 82.35% |
2016 | 217.44M | -13.93% |
2015 | 252.63M | -39.49% |
2014 | 417.51M | 119.12% |
The current Enterprise Value of Evoke Pharma, Inc. (EVOK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
115.71M
5-year avg
312.39M
10-year avg
333.50M
Evoke Pharma, Inc.’s Enterprise Value is less than Petros Pharmaceuticals, Inc. (3.58M), less than Cumberland Pharmaceuticals Inc. (20.16M), less than Agile Therapeutics, Inc. (7.87M), greater than PainReform Ltd. (-1709388.00), less than Aquestive Therapeutics, Inc. (497.34M), greater than Adamis Pharmaceuticals Corporation (-6593458674.00), greater than Guardion Health Sciences, Inc. (-10475955.00), less than AcelRx Pharmaceuticals, Inc. (1.19M), less than Eagle Pharmaceuticals, Inc. (16.86M), less than Regencell Bioscience Holdings Limited (101.59M), less than Procaps Group S.A. (473.19M), less than Incannex Healthcare Limited (40.05M), less than Journey Medical Corporation (110.20M), less than Jupiter Wellness, Inc. (45.30M), less than Avadel Pharmaceuticals plc (1.44B), less than Biofrontera Inc. (2.66M), less than Shuttle Pharmaceuticals Holdings, Inc. (5.35M), greater than Akanda Corp. (-3461700.00), less than China Pharma Holdings, Inc. (7.61M),
Company | Enterprise Value | Market cap |
---|---|---|
3.58M | $3.40M | |
20.16M | $15.93M | |
7.87M | $10.43M | |
-1709388.00 | $1.02M | |
497.34M | $470.32M | |
-6593458674.00 | $7.25M | |
-10475955.00 | $4.35M | |
1.19M | $14.58M | |
16.86M | $9.72M | |
101.59M | $104.49M | |
473.19M | $200.83M | |
40.05M | $45.53M | |
110.20M | $111.31M | |
45.30M | $49.33M | |
1.44B | $1.43B | |
2.66M | $5.60M | |
5.35M | $4.89M | |
-3461700.00 | $2.20M | |
7.61M | $4.29M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Evoke Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Evoke Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Evoke Pharma, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Evoke Pharma, Inc. (EVOK)?
What is the 3-year average Enterprise Value for Evoke Pharma, Inc. (EVOK)?
What is the 5-year average Enterprise Value for Evoke Pharma, Inc. (EVOK)?
How does the current Enterprise Value for Evoke Pharma, Inc. (EVOK) compare to its historical average?